Interactions between inflammatory activation and endothelial dysfunction selectively modulate valve disease progression in patients with bicuspid aortic valve

Heart

Volumn 100, Issue 10, 2014, Pages 800-805

  Ali, Onn A ^a,b   Chapman, Matthew ^a,b   Nguyen, Thanh H ^a,b,c   Chirkov, Yuliy Y ^a,b,c   Heresztyn, Tamila ^a,b,c   Mundisugih, Juan ^a,b   Horowitz, John D ^a,b  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c Digestive Disease Research Centre   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MYELOPEROXIDASE; N(G),N(G) DIMETHYLARGININE;

ADULT; AORTA DISEASE; AORTA VALVE; AORTA VALVE DISEASE; ARTICLE; ASCENDING AORTA; BICUSPID AORTIC VALVE; CARDIOVASCULAR MAGNETIC RESONANCE; CASE CONTROL STUDY; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TRANSTHORACIC ECHOCARDIOGRAPHY;

AORTA; AORTIC VALVE; ARGININE; BIOLOGICAL MARKERS; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; ENDOTHELIUM, VASCULAR; FEMALE; FOLLOW-UP STUDIES; HEART VALVE DISEASES; HUMANS; INFLAMMATION; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE; PEROXIDASE; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; VASODILATION;

EID: 84899497319     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2014-305509     Document Type: Article

References (29)

1. Yener N, Oktar GL, Erer D, et al. Bicuspid aortic valve. Ann Thorac Cardiovasc Surg 2002;8:264-7.
2. Jackson V, Petrini J, Caidahl K, et al. Bicuspid aortic valve leaflet morphology in relation to aortic root morphology: A study of 300 patients undergoing open-heart surgery. Eur J Cardiothorac Surg 2011;40:e118-124.
3. Girdauskas E, Borger MA, Secknus MA, et al. Is aortopathy in bicuspid aortic valve disease a congenital defect or a result of abnormal hemodynamics? A critical reappraisal of a one-sided argument. Eur J Cardiothorac Surg 2011;39:809-14.
4. Siu SC, Silversides CK. Bicuspid aortic valve disease. J Am Coll Cardiol 2010;55:2789-800.
5. Rossi A, van der Linde D, Yap SC, et al. Ascending aorta dilatation in patients with bicuspid aortic valve stenosis: a prospective CMR study. Eur Radiol 2013;23:642-9.
6. Schaefer BM, Lewin MB, Stout KK, et al. The bicuspid aortic valve: an integrated phenotypic classification of leaflet morphology and aortic root shape. Heart 2008;94:1634-8.
7. Kang JW, Song HG, Yang DH, et al. Association between bicuspid aortic valve phenotype and patterns of valvular dysfunction and bicuspid aortopathy: comprehensive evaluation using mdct and echocardiography. JACC Cardiovasc Imaging 2013;6:150-61.
8. Forte A, Della Corte A, Grossi M, et al. Early cell changes and tgfbeta pathway alterations in the aortopathy associated with bicuspid aortic valve stenosis. Clin Sci (Lond) 2013;124:97-108.
9. LeMaire SA, Wang X, Wilks JA, et al. Matrix metalloproteinases in ascending aortic aneurysms: bicuspid versus trileaflet aortic valves. J Surg Res 2005;123:40-8. (Pubitemid 40094643)
10. Tzemos N, Lyseggen E, Silversides C, et al. Endothelial function, carotid-femoral stiffness, and plasma matrix metalloproteinase-2 in men with bicuspid aortic valve and dilated aorta. J Am Coll Cardiol 2010;55:660-8.
11. Aicher D, Urbich C, Zeiher A, et al. Endothelial nitric oxide synthase in bicuspid aortic valve disease. Ann Thorac Surg 2007;83:1290-4. (Pubitemid 46440782)
12. Lee TC, Zhao YD, Courtman DW, et al. Abnormal aortic valve development in mice lacking endothelial nitric oxide synthase. Circulation 2000;101:2345-8. (Pubitemid 30329122)
13. O'Brien B, Schoenhagen P, Kapadia SR, et al. Integration of 3d imaging data in the assessment of aortic stenosis: impact on classification of disease severity. Circulation Cardiovasc Imaging 2011;4:566-73.
14. Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the international brachial artery reactivity task force. J Am Coll Cardiol 2002;39:257-65. (Pubitemid 34084631)
15. Fleissner F, Thum T. Critical role of the nitric oxide/reactive oxygen species balance in endothelial progenitor dysfunction. Antioxid Redox Signal 2011;15:933-48.
16. Gossl M, Khosla S, Zhang X, et al. Role of circulating osteogenic progenitor cells in calcific aortic stenosis. J Am Coll Cardiol 2012;60:1945-53.
17. Rajendran S, Willoughby SR, Chan WP, et al. Polycystic ovary syndrome is associated with severe platelet and endothelial dysfunction in both obese and lean subjects. Atherosclerosis 2009;204:509-14.
18. Chirkov YY, Holmes AS, Willoughby SR, et al. Association of aortic stenosis with platelet hyperaggregability and impaired responsiveness to nitric oxide. Am J Cardiol 2002;90:551-4.
19. Chirkov YY, Holmes AS, Willoughby SR, et al. Stable angina and acute coronary syndromes are associated with nitric oxide resistance in platelets. J Am Coll Cardiol 2001;37:1851-7. (Pubitemid 32499970)
20. Boger RH. Asymmetric dimethylarginine (adma) modulates endothelial function-therapeutic implications. Vasc Med 2003;8:149-51. (Pubitemid 38220191)
21. Heresztyn T, Worthley MI, Horowitz JD. Determination of l-arginine and ng, ng- and ng, ng' -dimethyl-l-arginine in plasma by liquid chromatography as accq-fluor fluorescent derivatives. J Chromatogr B Analyt Technol Biomed Life Sci 2004;805:325-9. (Pubitemid 38596755)
22. Ferencik M, Pape LA. Changes in size of ascending aorta and aortic valve function with time in patients with congenitally bicuspid aortic valves. Am J Cardiol 2003;92:43-6. (Pubitemid 36782307)
23. Chan WP, Ngo DT, Sverdlov AL, et al. Premature aging of cardiovascular/platelet function in polycystic ovarian syndrome. Am J Med 2013;126:640 e641-647.
24. Chen K, Thomas SR, Keaney JF Jr. Beyond LDL oxidation: ROS in vascular signal transduction. Free Radic Biol Med 2003;35:117-32. (Pubitemid 36835912)
25. Sanchez PL, Santos JL, Kaski JC, et al. Relation of circulating C-reactive protein to progression of aortic valve stenosis. Am J Cardiol 2006;97:90-3. (Pubitemid 41828129)
26. von Leitner EC, Klinke A, Atzler D, et al. Pathogenic cycle between the endogenous nitric oxide synthase inhibitor asymmetrical dimethylarginine and the leukocyte-derived hemoprotein myeloperoxidase. Circulation 2011;124:2735-45.
27. Balistreri CR, Pisano C, Candore G, et al. Focus on the unique mechanisms involved in thoracic aortic aneurysm formation in bicuspid aortic valve versus tricuspid aortic valve patients: clinical implications of a pilot study. Eur J Cardiothorac Surg 2013;43:e180-186.
28. Vaturi M, Perl L, Leshem-Lev D, et al. Circulating endothelial progenitor cells in patients with dysfunctional versus normally functioning congenitally bicuspid aortic valves. Am J Cardiol 2011;108:272-6.
29. Ngo DT, Sverdlov AL, Horowitz JD. Prevention of aortic valve stenosis: a realistic therapeutic target? Pharmacol Ther 2012;135:78-93.